Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1

Endocrinology

Volumn 150, Issue 4, 2009, Pages 1697-1704

  Gerin, Isabelle ^a   Louis, Gwendolyn W ^a   Zhang, Xuan ^b   Prestwich, Tyler C ^a   Kumar, T Rajendra ^b   Myers Jr , Martin G ^a   MacDougald, Ormond A ^a,c   Nothnick, Warren B ^b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c 7620 Medical Sciences II ^*  (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FEEDING; FEMALE; FOOD INTAKE; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HORMONE ACTION; HYPERLEPTINEMIA; HYPERPHAGIA; HYPOTHALAMUS; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; WEIGHT GAIN;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; AGING; ANIMALS; BODY WEIGHT; EATING; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HYPERPHAGIA; LEPTIN; MALE; MICE; MICE, MUTANT STRAINS; OBESITY; POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 63849084824     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1409     Document Type: Article

References (48)

1. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR 2002 Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51:1093-1101
2. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S 2003 Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278:11888-11896
3. Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ 2006 A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 125:577-591
4. Glowinska-Olszewska B, Urban M 2007 Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 56:799 -805
5. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M, Fasshauer M 2007 Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Eur J Endocrinol 156:257-261
6. Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen HR 2003 Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 89:696-704
7. Lijnen HR, Van HB, Frederix L, Rio MC, Collen D 2002 Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost 87:530 -535
8. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D 2002 Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 22:374-379
9. Demeulemeester D, Collen D, Lijnen HR 2005 Effect of matrix metallopro- teinase inhibition on adipose tissue development. Biochem Biophys Res Commun 329:105-110
10. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
11. Elmquist JK, Elias CF, Saper CB 1999 From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232
12. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK 1999 Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23:775-786
13. Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M, Low MJ 2003 A role for the endogenous opioid β-endorphin in energy ho- meostasis. Endocrinology 144:1753-1760
14. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ 2001 Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480 -484
15. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melano-cortinergicneurons in feedingandtheagouti obesitysyndrome. Nature 385:165-168
16. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW 1997 Melanocortin receptors in leptin effects. Nature 390:349
17. Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/obmice by the loss of neuropeptide Y. Science 274:1704-1707
18. Bates SH, Stearns WH, DundonTA, SchubertM, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers Jr MG 2003 STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856 -859
19. Breen TL, Conwell IM, Wardlaw SL 2005 Effects offasting,leptin, andinsulin on AGRP and POMC peptide release in the hypothalamus. Brain Res 1032:141-148
20. Korner J, Savontaus E, Chua Jr SC, Leibel RL, Wardlaw SL 2001 Leptinregulation of Agrp and Npy mRNA in the rathypothalamus. J Neuroendocrinol 13:959-966
21. Elmquist JK, Coppari R, Balthasar N, Ichinose M, Lowell BB 2005 Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 493:63-71
22. Schwartz MW2006 Central nervous system regulation of food intake. Obesity (Silver Spring) 14(Suppl 1):1S-8S
23. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua Jr S, Elmquist JK, Lowell BB 2006 Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body- weight homeostasis. Neuron 49:191-203
24. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, Thurmon JJ, Marinelli M, DiLeone RJ 2006 Leptin receptor signaling in midbrain do- pamine neurons regulates feeding. Neuron 51:801-810
25. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS 2006 Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51:811-822
26. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE 1992 The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319:218 -245
27. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E 1996 A role for melanin- concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247
28. Beuckmann CT, Yanagisawa M 2002 Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med 80:329 -342
29. Segal-LiebermanG, Bradley RL, KokkotouE, Carlson M, Trombly DJ, Wang X, Bates S, Myers Jr MG, Flier JS, Maratos-Flier E 2003 Melanin- concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA 100:10085-10090
30. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M 1998 Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585
31. Pinto S, Roseberry AG, LiuH, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL 2004 Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304:110 -115
32. Nothnick WB 2001 Reduction in reproductive lifespan of tissue inhibitor ofmetalloproteinase 1 (TIMP-1)-deficient female mice. Reproduction 122:923-927
33. Nothnick WB 2003 Tissue inhibitor ofmetalloproteinase-1 (TIMP-1) deficient mice display reduced serum progesterone levels during corpus luteum development. Endocrinology 144:5-8
34. Zhou HE, Zhang X, Nothnick WB 2004 Disruption of the TIMP-1 gene product is associated with accelerated endometrial gland formation during early postnatal uterine development. Biol Reprod 71:534 -539
35. NothnickWB, Zhang X, ZhouHE 2004 Steroidal regulation of uterine edema and tissue inhibitors of metalloproteinase (TIMP)-3 messenger RNA expression is altered in TIMP-1-deficient mice. Biol Reprod 70:500 -508
36. Soloway PD, Alexander CM, Werb Z, Jaenisch R 1996 Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene 13:2307-2314
37. Bjornholm M, Munzberg H, Leshan RL, Villanueva EC, Bates SH, Louis GW, Jones JC, Ishida-Takahashi R, Bjorbaek C, Myers Jr MG 2007 Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest 117:1354 -1360
38. Merciris D, Schiltz C, Legoupil N, Marty-Morieux C, de Vernejoul MC, Geoffroy V 2007 Over-expressionofTIMP-1 in osteoblasts increases theanabolic response to PTH. Bone 40:75-83
39. Riachi M, Himms-Hagen J, Harper ME 2004 Percent relative cumulative frequency analysis in indirect calorimetry: application to studies of transgenic mice. Can J Physiol Pharmacol 82:1075-1083
40. Cao Q, Mak KM, Ren C, Lieber CS 2004 Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem 279:4292-4304
41. Lin S, Saxena NK, Ding X, Stein LL, Anania FA 2006 Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol 20:3376-3388
42. Byrne LC, Zhou Z, Tryggvason K, Hokfelt T, Fetissov SO 2004 Altered NPY and AgRP in membrane type-1 matrix metalloproteinase-deficient mice. Neuroreport 15: 569-574
43. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E 2003 Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 89:249 -255
44. Wortley KE, Anderson KD, Yasenchak J, Murphy A, Valenzuela D, Diano S, Yancopoulos GD, Wiegand SJ, Sleeman MW 2005 Agouti-related protein- deficient mice display an age-related lean phenotype. Cell Metab 2:421-427
45. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M 2001 To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24:429-458
46. Jung KK, LiuXW, Chirco R, FridmanR, Kim HR 2006 Identification ofCD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J 25:3934-3942
47. Hoe HS, Cooper MJ, Burns MP, Lewis PA, van der Brug M, Chakraborty G, Cartagena CM, PakDT, CooksonMR, RebeckGW2007 The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J Neurosci 27:10895-10905
48. Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, BrewK, Nagase H, Stangl M, vonWeyhernCW, Brucher BL, Brand K, Coussens LM, Edwards DR, Kruger A 2007 Tissue inhibitor ofmetalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67:8615-8623